alovudine has been researched along with Cancer of the Thyroid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Traglia, S; Galli, F; Lauri, C; Pizzichini, P; Signore, A | 1 |
Aridome, K; Jinguji, M; Kajiya, Y; Mori, S; Nakajo, M; Suenaga, T; Tanaka, S | 1 |
Bläser, D; Kuwert, T; Maschauer, S; Prante, O | 1 |
1 review(s) available for alovudine and Cancer of the Thyroid
Article | Year |
---|---|
Current status of PET imaging of differentiated thyroid cancer with second generation radiopharmaceuticals.
Topics: Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Image Enhancement; Iodine Radioisotopes; Methionine; Radionuclide Imaging; Radiopharmaceuticals; Thyroid Neoplasms; Whole Body Imaging | 2015 |
2 other study(ies) available for alovudine and Cancer of the Thyroid
Article | Year |
---|---|
High FDG and low FLT uptake in a thyroid papillary carcinoma incidentally discovered by FDG PET/CT.
Topics: Biological Transport; Carcinoma; Carcinoma, Papillary; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Incidental Findings; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2012 |
In vitro characterization of the thyroidal uptake of O-(2-[(18)F]fluoroethyl)-L-tyrosine.
Topics: Animals; Cells, Cultured; Dideoxynucleosides; Humans; Metabolic Clearance Rate; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Species Specificity; Thyroid Gland; Thyroid Neoplasms | 2007 |